Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Fung

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|March 7, 2006
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovirMunira Hussain, Scott Fung, Evelien Libbrecht, et al.
Canadian Liver Journal|May 14, 2026
Optimal timing of infant post-vaccination serological testing for hepatitis B virus immunityCarla S Coffin, Scott Fung, Carla Osiowy, et al.
Plos One|March 20, 2015
Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trialsTram T Tran, Stuart C Gordon, Scott Fung, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot StudyAlexa Keeshan, Carla Coffin, Alicia Vachon, et al.
Journal of Medical Virology|May 28, 2014
Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDFYang Liu, Scott Fung, Edward J Gane, et al.
Gut|August 30, 2019
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)Kin Seng Liem, Scott Fung, David K Wong, et al.
Journal of Viral Hepatitis|September 8, 2020
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patientsKin Seng Liem, David K Wong, Scott Fung, et al.
Plos One|May 21, 2016
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver DiseaseMarialena Mouzaki, Alice Y Wang, Robert Bandsma, et al.
Annals of Surgical Oncology|May 9, 2014
Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american centerJonghun J Lee, Peter T W Kim, Sandra Fischer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2019
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis BKin Seng Liem, Colina Yim, Thomas D Ying, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|March 7, 2006
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovirMunira Hussain, Scott Fung, Evelien Libbrecht, et al.
Canadian Liver Journal|May 14, 2026
Optimal timing of infant post-vaccination serological testing for hepatitis B virus immunityCarla S Coffin, Scott Fung, Carla Osiowy, et al.
Plos One|March 20, 2015
Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trialsTram T Tran, Stuart C Gordon, Scott Fung, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot StudyAlexa Keeshan, Carla Coffin, Alicia Vachon, et al.
Journal of Medical Virology|May 28, 2014
Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDFYang Liu, Scott Fung, Edward J Gane, et al.
Gut|August 30, 2019
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)Kin Seng Liem, Scott Fung, David K Wong, et al.
Journal of Viral Hepatitis|September 8, 2020
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patientsKin Seng Liem, David K Wong, Scott Fung, et al.
Plos One|May 21, 2016
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver DiseaseMarialena Mouzaki, Alice Y Wang, Robert Bandsma, et al.
Annals of Surgical Oncology|May 9, 2014
Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american centerJonghun J Lee, Peter T W Kim, Sandra Fischer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2019
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis BKin Seng Liem, Colina Yim, Thomas D Ying, et al.
Pageof 6